MY7400210A - Pharmaceutical preparations having an adrenocorticotropic activity - Google Patents

Pharmaceutical preparations having an adrenocorticotropic activity

Info

Publication number
MY7400210A
MY7400210A MY210/74A MY7400210A MY7400210A MY 7400210 A MY7400210 A MY 7400210A MY 210/74 A MY210/74 A MY 210/74A MY 7400210 A MY7400210 A MY 7400210A MY 7400210 A MY7400210 A MY 7400210A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical preparations
adrenocorticotropic
activity
adrenocorticotropic activity
preparations
Prior art date
Application number
MY210/74A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MY7400210A publication Critical patent/MY7400210A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MY210/74A 1967-07-10 1974-12-30 Pharmaceutical preparations having an adrenocorticotropic activity MY7400210A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH977467 1967-07-10

Publications (1)

Publication Number Publication Date
MY7400210A true MY7400210A (en) 1974-12-31

Family

ID=4355521

Family Applications (1)

Application Number Title Priority Date Filing Date
MY210/74A MY7400210A (en) 1967-07-10 1974-12-30 Pharmaceutical preparations having an adrenocorticotropic activity

Country Status (9)

Country Link
US (1) US3632743A (et)
BE (1) BE717820A (et)
CY (1) CY752A (et)
DE (1) DE1767927A1 (et)
FR (2) FR8155M (et)
GB (1) GB1230472A (et)
IE (1) IE32559B1 (et)
MY (1) MY7400210A (et)
NL (1) NL6809695A (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862928A (en) * 1969-07-09 1975-01-28 Akzona Inc Psychopharmacological hexa-peptides containing a d-phenylalanyl residue
US3954975A (en) * 1972-02-17 1976-05-04 Ciba-Geigy Corporation Salts of ACTH-peptides and processes for their manufacture
BE795788A (nl) * 1972-02-22 1973-08-22 Akzo Nv Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2254043C2 (de) * 1972-11-04 1985-01-24 Hoechst Ag, 6230 Frankfurt LH-Releasing Hormon zur nasalen Applikation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
IT1204434B (it) * 1986-01-15 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
US6264974B1 (en) 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine
US6660715B2 (en) * 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
CN1738600A (zh) * 2002-11-12 2006-02-22 特瓦制药工业有限公司 用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
TW200815048A (en) * 2006-06-05 2008-04-01 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék

Also Published As

Publication number Publication date
CY752A (en) 1974-08-31
IE32559L (en) 1969-01-10
DE1767927A1 (de) 1971-09-30
FR8156M (et) 1970-08-24
US3632743A (en) 1972-01-04
FR8155M (et) 1970-08-24
IE32559B1 (en) 1973-09-19
BE717820A (et) 1969-01-09
NL6809695A (et) 1969-01-14
GB1230472A (et) 1971-05-05

Similar Documents

Publication Publication Date Title
CY752A (en) Pharmaceutical preparations having an adrenocorticotropic activity
IL26065A (en) Dual medicinal vial
GB1165990A (en) Track-Set
IL30165A0 (en) Tablets
IL31125A0 (en) Tablet
USD202467S (en) Pharmaceutical tablets
PH10958A (en) Tablet preparation
AU425946B2 (en) Pharmaceutical preparations having an adrenocorticotropic activity
AU4036868A (en) Pharmaceutical preparations having an adrenocorticotropic activity
IL31286A0 (en) 5-nitro-2-furfurylideneamino-oxazolidinone compounds and their preparations
AU427061B2 (en) Pharmaceutical preparations
CA760961A (en) Pharmaceutical preparations
IE31685L (en) Pharmaceutical preparation
CA766546A (en) Syringe
AU4572468A (en) Pharmaceutical preparations
CA770141A (en) Aminobenzophenone derivatives
IE31147L (en) Injectible preparations
CA752595A (en) Slaughtering
AU428126B2 (en) Pharmaceutical preparations and processes
CA762425A (en) Therapeutic agent
CA29126S (en) Gameboard
AU1137866A (en) Syringe
CA750388A (en) 1-trialcoxy-benzyl piperazines
CA28985S (en) Capsule
IE31206L (en) Pharmaceutical composition